For the quarter ended January 2025, HealthEquity (HQY) reported revenue of $311.82 million, up 18.8% over the same period last year. EPS came in at $0.69, compared to $0.63 in the year-ago quarter.

HealthEquity (HQY) stock dropped over 13% aftermarket trading following ... Healthequity’s strong fundamentals and earnings performance, coupled with the pro-HSA political landscape, bolster her ...

HealthEquity, Inc. HQY has been gaining from its business model and strategy. The optimism, led by a solid third-quarter fiscal 2025 performance ... highlights the one stock set to climb highest.

investors and analysts are closely monitoring its performance and future prospects. According to InvestingPro analysis, HealthEquity’s stock currently appears to be trading near its Fair Value ...

Despite its strong performance, HealthEquity faces several challenges ... You can also see if HQY appears on our undervalued or overvalued stock lists. These tools provide a clearer picture ...

Analysts on Wall Street project that HealthEquity (HQY ... role in predicting the possible reactions of investors toward the stock. Multiple empirical studies have consistently shown a strong ...

On Tuesday, HealthEquity, Inc. (NASDAQ ... that the company’s overall financial and operational performance will keep improving once temporary extra costs subside. Price Action: HQY stock is down 18.9 ...

HealthEquity, Inc. (NASDAQ:HQY) stock had a great 2024 ... Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether ...

Despite its strong performance, HealthEquity faces several challenges and risks that ... You can also see if HQY appears on our undervalued or overvalued stock lists. These tools provide a clearer ...

investors and analysts are closely monitoring its performance and future prospects. According to InvestingPro analysis, HealthEquity’s stock currently appears to be trading near its Fair Value, with ...